The trial is pitched at marketing approval for Dimerix’s therapy, DMX-200. EMvision Medical Devices (ASX:EMV) is also getting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback